138 related articles for article (PubMed ID: 22241152)
1. [Prognosis of 75 patients with juvenile myelomonocytic leukemia: prospective study by MDS committee in the Japanese Society of Pediatric Hematology].
Yoshida N; Hirabayashi S; Watanabe S; Zaike Y; Tsuchida M; Yoshimi A; Masunaga A; Otsuka Y; Ito M; Kojima S; Nakahata T; Manabe A
Rinsho Ketsueki; 2011 Dec; 52(12):1853-8. PubMed ID: 22241152
[TBL] [Abstract][Full Text] [Related]
2. Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications.
Manabe A; Yoshimasu T; Ebihara Y; Yagasaki H; Wada M; Ishikawa K; Hara J; Koike K; Moritake H; Park YD; Tsuji K; Nakahata T;
J Pediatr Hematol Oncol; 2004 Oct; 26(10):636-41. PubMed ID: 15454834
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of 15 children with juvenile myelomonocytic leukaemia who developed blast crisis: MDS Committee of Japanese Society of Paediatric Haematology/Oncology.
Honda Y; Tsuchida M; Zaike Y; Masunaga A; Yoshimi A; Kojima S; Ito M; Kikuchi A; Nakahata T; Manabe A
Br J Haematol; 2014 Jun; 165(5):682-7. PubMed ID: 24588411
[TBL] [Abstract][Full Text] [Related]
5. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).
Hasle H; Baumann I; Bergsträsser E; Fenu S; Fischer A; Kardos G; Kerndrup G; Locatelli F; Rogge T; Schultz KR; Starý J; Trebo M; van den Heuvel-Eibrink MM; Harbott J; Nöllke P; Niemeyer CM;
Leukemia; 2004 Dec; 18(12):2008-14. PubMed ID: 15496981
[TBL] [Abstract][Full Text] [Related]
6. Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia.
Maschan AA; Khachatrian LA; Solopova GG; Ossipova EY; Baidun LV; Dmitrieva SV; Maschan MA; Resnik IB
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e32-4. PubMed ID: 21102353
[TBL] [Abstract][Full Text] [Related]
7. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders.
Occhipinti E; Correa H; Yu L; Craver R
Pediatr Blood Cancer; 2005 Mar; 44(3):240-4. PubMed ID: 15368549
[TBL] [Abstract][Full Text] [Related]
10. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
Bresolin S; Zecca M; Flotho C; Trentin L; Zangrando A; Sainati L; Stary J; de Moerloose B; Hasle H; Niemeyer CM; Te Kronnie G; Locatelli F; Basso G
J Clin Oncol; 2010 Apr; 28(11):1919-27. PubMed ID: 20231685
[TBL] [Abstract][Full Text] [Related]
11. Juvenile myelomonocytic leukaemia: a case series.
Azma RZ; Zarina AL; Hamidah A; Jamal R; Sharifah NA; Ainoon O; Hamidah NH
Malays J Pathol; 2009 Dec; 31(2):121-8. PubMed ID: 20514855
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytosis associated with leukemia: a striking association with juvenile myelomonocytic leukemia.
Unal S; Cetin M; Kutlay NY; Elmas SA; Gumruk F; Tukun A; Tuncer M; Gurgey A
Ann Hematol; 2010 Apr; 89(4):359-64. PubMed ID: 19798502
[TBL] [Abstract][Full Text] [Related]
13. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients.
Tüfekçi Ö; Koçak Ü; Kaya Z; Yenicesu İ; Albayrak C; Albayrak D; Yılmaz Bengoa Ş; Patıroğlu T; Karakükçü M; Ünal E; Ünal İnce E; İleri T; Ertem M; Celkan T; Özdemir GN; Sarper N; Kaçar D; Yaralı N; Özbek NY; Küpesiz A; Karapınar T; Vergin C; Çalışkan Ü; Tokgöz H; Sezgin Evim M; Baytan B; Güneş AM; Yılmaz Karapınar D; Karaman S; Uygun V; Karasu G; Yeşilipek MA; Koç A; Erduran E; Atabay B; Öniz H; Ören H
Turk J Haematol; 2018 Mar; 35(1):27-34. PubMed ID: 28179213
[TBL] [Abstract][Full Text] [Related]
14. [Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology].
Gotoh A; Ohyashiki K; Oshimi K; Usui N; Hotta T; Dan K; Ikeda Y; ;
Rinsho Ketsueki; 2006 Dec; 47(12):1521-7. PubMed ID: 17233470
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I.
Suttorp M; Claviez A; Bader P; Peters C; Gadner H; Ebell W; Dilloo D; Kremens B; Kabisch H; Führer M; Zintl F; Göbel U; Klingebiel T
Klin Padiatr; 2009; 221(6):351-7. PubMed ID: 19890786
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of juvenile myelomonocytic leukemia(JMML)].
Adachi S; Nakahata T
Nihon Rinsho; 2001 Dec; 59(12):2401-6. PubMed ID: 11766346
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.
Locatelli F; Crotta A; Ruggeri A; Eapen M; Wagner JE; Macmillan ML; Zecca M; Kurtzberg J; Bonfim C; Vora A; Díaz de Heredia C; Teague L; Stein J; O'Brien TA; Bittencourt H; Madureira A; Strahm B; Peters C; Niemeyer C; Gluckman E; Rocha V
Blood; 2013 Sep; 122(12):2135-41. PubMed ID: 23926304
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
